Conceivable Life Sciences

C:EGG uses full-depth imaging and OCT to detect oocytes that conventional microscopy misses, especially in cloudy or blood-tinged follicular fluid.

SiD provides objective motility data for embryologist-led sperm selection for ICSI. Four independent studies showed improved blastocyst formation, especially for older patients.

The page presents insights on IVF innovation, automation, and the future of fertility care from Conceivable Life Sciences and industry leaders.

C:SPERM, part of AURA, uses centrifuge-free sperm preparation to protect DNA integrity before injection and select healthier sperm.

Joshua Abram & Alan Murray are serial entrepreneurs and Co-Founders of Conceivable, driving innovation in fertility tech with expertise and scaling ventures.

Dr. Alejandro Chavez-Badiola is Co-Founder & Chief Medical Officer at Conceivable, bringing clinical leadership to scale reproductive health globally.

Brian Bixon is SVP of Product, leading the development of AI‑powered IVF automation systems with a focus on precision, scalability, and operational excellence.

Dr. Jacques Cohen is a pioneering embryologist and ART innovator whose decades of leadership in IVF science power breakthroughs in fertility automation.

The page describes Conceivable Life Sciences' mission, vision, founding team, and use of automation and AI in fertility care.

Conceivable Life Sciences accepts press inquiries through its contact form or email and has offices in New York, London, and Guadalajara.

Conceivable Life Sciences: pioneering the world’s first AI-powered automated IVF lab (AURA) to lower cost, increase access, and improve fertility outcomes.”

Conceivable Life Sciences' Privacy Policy describes how the company collects, uses, and protects personal information when people access its website and services.

Conceivable's Terms of Service outline the terms for accessing and using its website and services, including its AI-powered IVF automation technology.